HomeNVAX • NASDAQ
Novavax, Inc.
$21.00
After Hours:
$21.08
(0.38%)+0.080
Closed: Sep 23, 7:59:24 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$22.44
Day range
$20.46 - $22.37
Year range
$20.46 - $260.69
Market cap
1.64B USD
Avg Volume
4.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Jun 2022Y/Y change
Revenue
185.92M-37.61%
Operating expense
108.16M47.84%
Net income
-510.48M-44.89%
Net profit margin
-274.56-132.24%
Earnings per share
-6.53-37.47%
EBITDA
-476.24M-38.68%
Effective tax rate
-0.28%
Total assets
Total liabilities
(USD)Jun 2022Y/Y change
Cash and short-term investments
1.38B-33.70%
Total assets
2.62B-4.60%
Total liabilities
3.04B51.69%
Total equity
-416.95M
Shares outstanding
78.22M
Price to book
-4.21
Return on assets
-44.24%
Return on capital
-326.94%
Net change in cash
(USD)Jun 2022Y/Y change
Net income
-510.48M-44.89%
Cash from operations
-170.90M-218.34%
Cash from investing
-24.58M-90.50%
Cash from financing
4.66M111.99%
Net change in cash
-196.58M-309.87%
Free cash flow
-385.10M-255.49%
About
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus, as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19. Their vaccine, Nuvaxovid, was approved in the European Union at the end of 2021 and in Canada in February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca. Wikipedia
Founded
1987
Employees
1,541
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for